Feasibility of an affected sibling pair study in ischemic stroke - Results of a 2-center family history registry

被引:24
作者
Meschia, JF
Brown, RD
Brott, TG
Hardy, J
Atkinson, EJ
O'Brien, PC
机构
[1] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[2] Mayo Clin, Pharmacol Sect, Jacksonville, FL 32224 USA
[3] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA
关键词
cerebral infarction; feasibility studies; pedigree research; risk factors; genetic; stroke classification; stroke; ischemic;
D O I
10.1161/hs1201.099795
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-We sought to determine pedigree availability for a concordant sibling pair study of genetic risk factors in ischemic stroke. Methods-Probands with confirmed ischemic stroke were prospectively enrolled. Family histories were obtained by systematic interview. A study neurologist prospectively assigned stroke subtype. Results-Of 310 probands (median age, 75 years; range, 26 to 97 years; 48% women), 75% had at least 1 living sibling; 10%, at least 1 concordant living sibling; 2%, at least 1 concordant sibling living in the same city; and 7%, at least 1 concordant living and 1 discordant living sibling. Likelihood of having a concordant sibling increased significantly with proband age, even after adjustment for sibship size (P=0.002). Positive family history of stroke was not related to either proband stroke subtype or risk factor profile. Conclusions-Approximately 10 probands were screened to find 1 potentially concordant living sibling. A concordant sibling pair study should be multicentered and enable enrollment of siblings from diverse geographic areas.
引用
收藏
页码:2939 / 2941
页数:3
相关论文
共 4 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]  
HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541
[3]   A full genome scan for late onset Alzheimer's disease [J].
Kehoe, P ;
Wavrant-De Vrieze, F ;
Crook, R ;
Wu, WS ;
Holmans, P ;
Fenton, I ;
Spurlock, G ;
Norton, N ;
Williams, H ;
Williams, N ;
Lovestone, S ;
Perez-Tur, J ;
Hutton, M ;
Chartier-Harlin, MC ;
Shears, S ;
Roehl, K ;
Booth, J ;
Van Voorst, W ;
Ramic, D ;
Williams, J ;
Goate, A ;
Hardy, J ;
Owen, MJ .
HUMAN MOLECULAR GENETICS, 1999, 8 (02) :237-245
[4]  
MESCHIA JF, 2000, J STROKE CEREBROVASC, V9, P276